Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
What Is the Current Size and Annual Growth Rate of the Blood Platelets Market?
The blood platelets market size has grown strongly in recent years. It will grow from $6.27 billion in 2024 to $6.7 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to growing number of surgeries, growing incidence of traumatic injuries, prevalence of autoimmune diseases, rising incidence of chronic diseases and growing prevalence of thrombocytopenia.
The blood platelets market size is expected to see strong growth in the next few years. It will grow to " $8.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to growing number of trauma cases, rise in the number of blood banks, growing preference for allogeneic blood transfusion therapies, increasing aging population, and rise in the need for platelets in wound healing. Major trends in the forecast period include automated platelet apheresis systems, advanced platelet storage technologies, platelet-rich plasma (PRP) therapies, shift toward leukoreduced platelets, artificial platelet substitutes, gene editing for platelet disorders and automated donor screening.
Get your free report sample today:
What Are the Primary Factors Driving the Blood Platelets Market?
The increasing prevalence of blood disorders is expected to propel the growth of the blood platelets market going forward. Blood disorders refer to conditions that affect the function, production or components of blood, including red blood cells, white blood cells, platelets or plasma, leading to issues such as anemia, clotting disorders or immune system deficiencies. The increasing prevalence of blood disorders is rising due to the aging population, as aging leads to a decline in bone marrow function, making older adults more susceptible to conditions like anemia, thrombocytopenia, and clotting disorders. Blood platelets enhance blood disorders treatments by regulating blood clotting, making them essential for preventing excessive bleeding and supporting wound healing. For instance, in April 2024, according to the Perth Blood Institute, an Australia-based non-profit organization, the number of people identified with hemophilia (a rare genetic disorder where the blood doesn’t clot properly due to a lack of clotting factor leading to prolonged bleeding) reached 257,146 in 2022, rising from 233,577 in 2021. Therefore, the increasing prevalence of blood disorders is driving the growth of the blood platelets market.
How Is the Blood Platelets Market Categorized Based on Key Segments?
The blood plateletsmarket covered in this report is segmented –
1) By Platelet Type: Whole Blood Derived Platelets; Apheresis Derived Platelets
2) By Application: Platelet Function Disorder; Hemophilia; Thrombocytopenia; Perioperative Indication
3) By End-Users: Hospitals; Ambulatory Surgical Centers; Blood Banks; Research Laboratories; Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users
Subsegments:
1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets; Non-Leukocyte-Reduced Whole Blood Platelets; Pathogen-Reduced Whole Blood Platelets
2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets; Leukocyte-Reduced Apheresis Platelets; Pathogen-Reduced Apheresis Platelets
Which Emerging Trends Are Shaping the Future of the Blood Platelets Market?
Major companies operating in the blood platelet market are focusing on developing innovative solutions, such as platelet pooling to extend shelf life, enhance availability, and support blood centers in meeting growing transfusion demands. Platelet pooling refers to the process of combining platelets from multiple whole blood donations to create a single platelet unit for transfusion, improving availability, efficiency, and resource utilization in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. The innovation extends the shelf life of whole blood-derived platelets from five to seven days, enhancing platelet availability for transfusion. It also provides an alternative source of platelet supply to address rising demand and donor shortages, helping blood centers improve inventory management and reduce waste.
Who Are the Major Companies Operating in the Blood Platelets Market?
Major companies operating in the blood platelets market are Pfizer? Inc., Johnson & Johnson?, Bayer AG?, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma? Inc., LFB Group, Bio Products Laboratory Limited, Sanquin?, Macopharma, Biotest AG, Cerus Corporation?, ADMA Biologics Inc., Octapharma AG, Kamada Ltd.?, HemaCare
Get the detailed blood platelets market report today
Which Region Holds the Largest Share of the Blood Platelets Market?
North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood platelets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment